Dr. O’Neill has more than 25 years of experience in drug development, and medical and regulatory affairs. Formerly the chief medical officer and executive vice president of research and development at Sarepta Therapeutics, Dr. O’Neill spent 15 years at Biogen, holding leadership roles in development programs for Alzheimer’s disease, movement disorders, neurology, multiple sclerosis, pain, neuromuscular disease, gene and cell therapy, and rare diseases, and overseeing multiple global marketing approvals.
